Updates are available Correction dated 2019-04-25
Click to view Correction: https://doi.org/10.1007/s10637-019-00773-9
-
Authors
Inoue, Kenichi http://orcid.org/0000-0003-2686-8732
Ninomiya, Jun
Saito, Tsuyoshi
Okubo, Katsuhiko
Nakakuma, Takashi
Yamada, Hirofumi
Kimizuka, Kei
Higuchi, Tohru
,
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18ck0106307h0002)
- License Information
-
More Information
Article History
Received: 29 January 2019
Accepted: 1 March 2019
First Online: 8 March 2019
Change Date: 25 April 2019
Change Type: Correction
Change Details: The authors would like to note the replacement of Fig. 2b, for which Fig. 2a was placed erringly, with appropriate Fig. 2b.
Compliance with ethical standards
:
: Dr. Inoue received grant from Novartis, Pfizer, Chugai, Daiichi-Sankyo, Parexel/Puma Biotechnology, MSD, Bayer, Lilly, and Eisai during the conduct of the study. The other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors. The study protocol was approved by the Medical Ethics Committees of the participating institutions.
: Informed consent was obtained from all individual participants included in the study.
